1. 1
    Laurus Labs Targets 55-60 Gross Margin In FY26 On CDMO Expansion ☶ Care Government Finance Health Insurance Hospitals International Finance Macroeconomic Theory Pharmaceuticals Price Theory Production Theory
    authored by torrobot avatar torrobot 22 days ago |
    Archive.org Archive.today Ghostarchive
    | no comments

The CDMO segment will account for 50% of the company’s revenue in the medium to long term.

  1.